Friedberg, E. C. A brief history of the DNA repair field. Cell Res. 18, 3–7 (2008).

Article  CAS  Google Scholar 

Lindahl, T. Instability and decay of the primary structure of DNA. Nature 362, 709–715 (1993).

Article  CAS  Google Scholar 

Lindahl, T. & Nyberg, B. Rate of depurination of native deoxyribonucleic acid. Biochemistry 11, 3610–3618 (1972).

Article  CAS  Google Scholar 

Lindahl, T. & Barnes, D. E. Repair of endogenous DNA damage. Cold Spring Harb. Symp. Quant. Biol. 65, 127–134 (2000).

Article  CAS  Google Scholar 

Jackson, S. P. & Bartek, J. The DNA-damage response in human biology and disease. Nature 461, 1071–1078 (2009).

Article  CAS  Google Scholar 

Doudna, J. A. & Charpentier, E. The new frontier of genome engineering with CRISPR–Cas9. Science 346, 1258096 (2014).

Article  Google Scholar 

Barrangou, R. et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science 315, 1709–1712 (2007).

Article  CAS  Google Scholar 

Makarova, K. S. et al. Evolution and classification of the CRISPR–Cas systems. Nat. Rev. Microbiol. 9, 467–477 (2011).

Article  CAS  Google Scholar 

Przybyla, L. & Gilbert, L. A. A new era in functional genomics screens. Nat. Rev. Genet. 23, 89–103 (2022).

Article  CAS  Google Scholar 

Baskar, R., Lee, K. A., Yeo, R. & Yeoh, K.-W. Cancer and radiation therapy: current advances and future directions. Int. J. Med. Sci. 9, 193–199 (2012).

Article  Google Scholar 

Tchounwou, P. B., Dasari, S., Noubissi, F. K., Ray, P. & Kumar, S. Advances in our understanding of the molecular mechanisms of action of cisplatin in cancer therapy. J. Exp. Pharmacol. 13, 303–328 (2021).

Article  Google Scholar 

Zagnoli-Vieira, G. & Caldecott, K. W. Untangling trapped topoisomerases with tyrosyl-DNA phosphodiesterases. DNA Repair. 94, 102900 (2020).

Article  CAS  Google Scholar 

Hanahan, D. Hallmarks of cancer: new dimensions. Cancer Discov. 12, 31–46 (2022).

Article  CAS  Google Scholar 

Pilié, P. G., Tang, C., Mills, G. B. & Yap, T. A. State-of-the-art strategies for targeting the DNA damage response in cancer. Nat. Rev. Clin. Oncol. 16, 81–104 (2019).

Article  Google Scholar 

Dias, M. P., Moser, S. C., Ganesan, S. & Jonkers, J. Understanding and overcoming resistance to PARP inhibitors in cancer therapy. Nat. Rev. Clin. Oncol. 18, 773–791 (2021).

Article  Google Scholar 

Farmer, H. et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434, 917–921 (2005).

Article  CAS  Google Scholar 

Bryant, H. E. et al. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434, 913–917 (2005). Together with Farmer et al. (2005), this paper establishes that PARP inhibitors are strikingly and selectively toxic to cells bearing BRCA1 or BRCA2 deficiency, highlighting the potential for their use in HR-deficient cancers.

Article  CAS  Google Scholar 

Lord, C. J. & Ashworth, A. PARP inhibitors: synthetic lethality in the clinic. Science 355, 1152–1158 (2017).

Article  CAS  Google Scholar 

Pilger, D., Seymour, L. W. & Jackson, S. P. Interfaces between cellular responses to DNA damage and cancer immunotherapy. Genes Dev. 35, 602–618 (2021).

Article  CAS  Google Scholar 

Gourley, C. et al. Moving from poly(ADP-ribose) polymerase inhibition to targeting DNA repair and DNA damage response in cancer therapy. J. Clin. Oncol. 37, 2257–2269 (2019).

Article  CAS  Google Scholar 

Lord, C. J., McDonald, S., Swift, S., Turner, N. C. & Ashworth, A. A high-throughput RNA interference screen for DNA repair determinants of PARP inhibitor sensitivity. DNA Repair. 7, 2010–2019 (2008).

Article  CAS  Google Scholar 

Bartz, S. R. et al. Small interfering RNA screens reveal enhanced cisplatin cytotoxicity in tumor cells having both BRCA network and TP53 disruptions. Mol. Cell. Biol. 26, 9377–9386 (2006).

Article  CAS  Google Scholar 

Smogorzewska, A. et al. A genetic screen identifies FAN1, a Fanconi anemia-associated nuclease necessary for DNA interstrand crosslink repair. Mol. Cell 39, 36–47 (2010).

Article  CAS  Google Scholar 

O’Connell, B. C. et al. A genome-wide camptothecin sensitivity screen identifies a mammalian MMS22L–NFKBIL2 complex required for genomic stability. Mol. Cell 40, 645–657 (2010).

Article  Google Scholar 

Doil, C. et al. RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to allow accumulation of repair proteins. Cell 136, 435–446 (2009).

Article  CAS  Google Scholar 

Stewart, G. S. et al. The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling cascade at sites of DNA damage. Cell 136, 420–434 (2009).

Article  CAS  Google Scholar 

Paulsen, R. D. et al. A genome-wide siRNA screen reveals diverse cellular processes and pathways that mediate genome stability. Mol. Cell 35, 228–239 (2009).

Article  CAS  Google Scholar 

López-Saavedra, A. et al. A genome-wide screening uncovers the role of CCAR2 as an antagonist of DNA end resection. Nat. Commun. 7, 12364 (2016).

Article  Google Scholar 

Adamson, B., Smogorzewska, A., Sigoillot, F. D., King, R. W. & Elledge, S. J. A genome-wide homologous recombination screen identifies the RNA-binding protein RBMX as a component of the DNA-damage response. Nat. Cell Biol. 14, 318–328 (2012).

Article  CAS  Google Scholar 

Acevedo-Arozena, A. et al. ENU mutagenesis, a way forward to understand gene function. Annu. Rev. Genom. Hum. 9, 49–69 (2008).

Article  CAS  Google Scholar 

Blomen, V. A. et al. Gene essentiality and synthetic lethality in haploid human cells. Science 350, 1092–1096 (2015).

Article  CAS  Google Scholar 

O’Loughlin, T. A. & Gilbert, L. A. Functional genomics for cancer research: applications in vivo and in vitro. Annu. Rev. Cancer Biol. 3, 345–363 (2019).

Article  Google Scholar 

Forment, J. V. et al. Genome-wide genetic screening with chemically mutagenized haploid embryonic stem cells. Nat. Chem. Biol. 13, 12–14 (2017).

Article  CAS  Google Scholar 

Hsu, P. D., Lander, E. S. & Zhang, F. Development and applications of CRISPR–Cas9 for genome engineering. Cell 157, 1262–1278 (2014).

Article  CAS  Google Scholar 

Shalem, O., Sanjana, N. E. & Zhang, F. High-throughput functional genomics using CRISPR–Cas9. Nat. Rev. Genet. 16, 299–311 (2015).

Article  CAS  Google Scholar 

Shalem, O. et al. Genome-scale CRISPR–Cas9 knockout screening in human cells. Science 343, 84–87 (2014).

Article  CAS  Google Scholar 

Wang, T. et al. Identification and characterization of essential genes in the human genome. Science 350, 1096–1101 (2015).

Article  CAS  Google Scholar 

Wang, T., Wei, J. J., Sabatini, D. M. & Lander, E. S. Genetic screens in human cells using the CRISPR–Cas9 system. Science 343, 80–84 (2014).

Article  CAS  Google Scholar 

Koike-Yusa, H., Li, Y., Tan, E.-P., del Castillo Velasco-Herrera, M. & Yusa, K. Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library. Nat. Biotechnol. 32, 267–273 (2014).

Article  CAS  Google Scholar 

Hart, T. et al. High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities. Cell 163, 1515–1526 (2015).

Article  CAS  Google Scholar 

Gilbert, L. A. et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154, 442–451 (2013).

Article  CAS  Google Scholar 

Gilbert, L. A. et al. Genome-scale CRISPR-mediated control of gene repression and activation. Cell 159, 647–661 (2014).

Article  CAS  Google Scholar 

Perez-Pinera, P. et al. RNA-guided gene activation by CRISPR–Cas9-based transcription factors. Nat. Methods 10, 973–976 (2013).

Article  CAS  Google Scholar 

Kearns, N. A. et al. Functional annotation of native enhancers with a Cas9–histone demethylase fusion. Nat. Methods 12, 401–403 (2015).

Article  CAS  Google Scholar 

Thakore, P. I. et al. Highly specific epigenome editing by CRISPR–Cas9 repressors for silencing of distal regulatory elements. Nat. Methods 12, 1143–1149 (2015).

Article  CAS  Google Scholar 

Sanson, K. R. et al. Optimized libraries for CRISPR–Cas9 genetic screens with multiple modalities. Nat. Commun. 9, 5416 (2018).

Article  CAS  Google Scholar 

Iyer, V. S. et al. Designing custom CRISPR libraries for hypothesis-driven drug target discovery. Comput. Struct. Biotechnol. J. 18, 2237–2246 (2020).

Article  CAS  Google S